<DOC>
	<DOCNO>NCT00404430</DOCNO>
	<brief_summary>The main objective study evaluate predictive factor endothelial function wan acute exacerbation COPD . It act multivariate analysis determine respective weight parameter systemic inflammation , oxidative stress functional respiratory parameter functional respiratory parameter . In exacerbated Chronic Obstructive Pulmonary Disease ( COPD ) patient , augmentation hypoxia obstructive ventilatory disorder important . This correlated increase C-reactive Protein ( CRP ) inflammatory cytokine oxidative stress . It demonstrate endothelial dysfunction answer hypoxia . Since exacerbate COPD patient hypoxic case , suppose endothelial dysfunction exacerbation . So think find augmentation vascular resistance , show peripheral arterial tone high . And , certainly , play part physiopathology COPD exacerbation .</brief_summary>
	<brief_title>Protocol Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>We want judge improvement endothelial function remotely acute exacerbation ( 6 week ) . And would like correlate improvement variation oxidative stress , muscle strength , respiratory function systemic inflammation . We also would like find relation new hospitalization respiratory exacerbation initial value endothelial function . Then would like evaluate relationship cardiovascular risk COPD severity .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>COPD patient wan exacerbation : Male Female 18 year old VEF1/FCV &lt; 70 % COPD already know At moment respiratory failure , day enter hospital : Respiratory frequency &gt; 25 PaCO2 &gt; 45 mmHg pH &lt; 7.35 The day inclusion study : PH &gt; 7.33 end respiratory failure , 2 day continuation , 3 7 day post acute exacerbation continuation Fever &lt; 38.5 Patients sign inform consent form Stable COPD patient : Men woman 18 year old VEF1/FCV &lt; 70 % COPD already know Patients sign inform consent form Evolutive obvious infection CRP &gt; 100 inclusion Cardiac failure consider like major cause exacerbation cardiac insufficiency FEVG &lt; 45 % Smoker &gt; 10 cigarette day Antioxidant catch : Nacetylcystein , selenium , ascorbic acid , alpha tocopherol acetate… Evolutive neoplasia Antioxidant catch : Nacetylcystein , selenium , ascorbic acid , alpha tocopherol acetate… pregnant woman patient supervision trusteeship patient take part another clinical trial claustrophobia , patient allergic contrast agent like Gadolinium , presence material dissuade realization MRI ( pacemaker , implantable defibrillator , insulin pump , ferrometallic clip foreign body brain eye )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Endothelial function</keyword>
	<keyword>Peripheral Arterial Tone</keyword>
	<keyword>Systemic Inflammation</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Respiratory peripheral muscular function</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>COPD severity</keyword>
</DOC>